Metformin improved a heterologous prime-boost of dual-targeting cancer vaccines to inhibit tumor growth in a melanoma mouse model.
Guo Q, Wang L, Wuriqimuge, Dong L, Feng M, Bao X, Zhang K, Cai Z, Qu X, Zhang S, Wu J, Wu H, Wang C, Yu X, Kong W, Zhang H.
Guo Q, et al. Among authors: wu h, wu j.
Int Immunopharmacol. 2024 Feb 15;128:111431. doi: 10.1016/j.intimp.2023.111431. Epub 2024 Jan 19.
Int Immunopharmacol. 2024.
PMID: 38244520